Copyright Reports & Markets. All rights reserved.

Global Cardiopulmonary Autotransfusion System Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Cardiopulmonary Autotransfusion System Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Cardiopulmonary Autotransfusion System Market Size Growth Rate by Product
      • 1.4.2 Unwashed ATS
      • 1.4.3 Washed ATS
    • 1.5 Market by End User
      • 1.5.1 Global Cardiopulmonary Autotransfusion System Market Size Growth Rate by End User
      • 1.5.2 Heart Surgery
      • 1.5.3 Great Organ Transplant Surgery
      • 1.5.4 Other Surgery
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Cardiopulmonary Autotransfusion System Market Size
      • 2.1.1 Global Cardiopulmonary Autotransfusion System Revenue 2014-2025
      • 2.1.2 Global Cardiopulmonary Autotransfusion System Sales 2014-2025
    • 2.2 Cardiopulmonary Autotransfusion System Growth Rate by Regions
      • 2.2.1 Global Cardiopulmonary Autotransfusion System Sales by Regions
      • 2.2.2 Global Cardiopulmonary Autotransfusion System Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Cardiopulmonary Autotransfusion System Sales by Manufacturers
      • 3.1.1 Cardiopulmonary Autotransfusion System Sales by Manufacturers
      • 3.1.2 Cardiopulmonary Autotransfusion System Sales Market Share by Manufacturers
      • 3.1.3 Global Cardiopulmonary Autotransfusion System Market Concentration Ratio (CR5 and HHI)
    • 3.2 Cardiopulmonary Autotransfusion System Revenue by Manufacturers
      • 3.2.1 Cardiopulmonary Autotransfusion System Revenue by Manufacturers (2014-2019)
      • 3.2.2 Cardiopulmonary Autotransfusion System Revenue Share by Manufacturers (2014-2019)
    • 3.3 Cardiopulmonary Autotransfusion System Price by Manufacturers
    • 3.4 Cardiopulmonary Autotransfusion System Manufacturing Base Distribution, Product Types
      • 3.4.1 Cardiopulmonary Autotransfusion System Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Cardiopulmonary Autotransfusion System Product Type
      • 3.4.3 Date of International Manufacturers Enter into Cardiopulmonary Autotransfusion System Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Cardiopulmonary Autotransfusion System Sales by Product
    • 4.2 Global Cardiopulmonary Autotransfusion System Revenue by Product
    • 4.3 Cardiopulmonary Autotransfusion System Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Cardiopulmonary Autotransfusion System Breakdown Data by End User

    6 North America

    • 6.1 North America Cardiopulmonary Autotransfusion System by Countries
      • 6.1.1 North America Cardiopulmonary Autotransfusion System Sales by Countries
      • 6.1.2 North America Cardiopulmonary Autotransfusion System Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Cardiopulmonary Autotransfusion System by Product
    • 6.3 North America Cardiopulmonary Autotransfusion System by End User

    7 Europe

    • 7.1 Europe Cardiopulmonary Autotransfusion System by Countries
      • 7.1.1 Europe Cardiopulmonary Autotransfusion System Sales by Countries
      • 7.1.2 Europe Cardiopulmonary Autotransfusion System Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Cardiopulmonary Autotransfusion System by Product
    • 7.3 Europe Cardiopulmonary Autotransfusion System by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Cardiopulmonary Autotransfusion System by Countries
      • 8.1.1 Asia Pacific Cardiopulmonary Autotransfusion System Sales by Countries
      • 8.1.2 Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Cardiopulmonary Autotransfusion System by Product
    • 8.3 Asia Pacific Cardiopulmonary Autotransfusion System by End User

    9 Central & South America

    • 9.1 Central & South America Cardiopulmonary Autotransfusion System by Countries
      • 9.1.1 Central & South America Cardiopulmonary Autotransfusion System Sales by Countries
      • 9.1.2 Central & South America Cardiopulmonary Autotransfusion System Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Cardiopulmonary Autotransfusion System by Product
    • 9.3 Central & South America Cardiopulmonary Autotransfusion System by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Cardiopulmonary Autotransfusion System by Countries
      • 10.1.1 Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Countries
      • 10.1.2 Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Cardiopulmonary Autotransfusion System by Product
    • 10.3 Middle East and Africa Cardiopulmonary Autotransfusion System by End User

    11 Company Profiles

    • 11.1 Haemonetics
      • 11.1.1 Haemonetics Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Haemonetics Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Haemonetics Cardiopulmonary Autotransfusion System Products Offered
      • 11.1.5 Haemonetics Recent Development
    • 11.2 Medtronic
      • 11.2.1 Medtronic Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Medtronic Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Medtronic Cardiopulmonary Autotransfusion System Products Offered
      • 11.2.5 Medtronic Recent Development
    • 11.3 LivaNova
      • 11.3.1 LivaNova Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 LivaNova Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 LivaNova Cardiopulmonary Autotransfusion System Products Offered
      • 11.3.5 LivaNova Recent Development
    • 11.4 Fresenius Kabi
      • 11.4.1 Fresenius Kabi Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Fresenius Kabi Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Fresenius Kabi Cardiopulmonary Autotransfusion System Products Offered
      • 11.4.5 Fresenius Kabi Recent Development
    • 11.5 Terumo
      • 11.5.1 Terumo Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Terumo Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Terumo Cardiopulmonary Autotransfusion System Products Offered
      • 11.5.5 Terumo Recent Development
    • 11.6 Wandong Health Sources
      • 11.6.1 Wandong Health Sources Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Wandong Health Sources Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Wandong Health Sources Cardiopulmonary Autotransfusion System Products Offered
      • 11.6.5 Wandong Health Sources Recent Development

    12 Future Forecast

    • 12.1 Cardiopulmonary Autotransfusion System Market Forecast by Regions
      • 12.1.1 Global Cardiopulmonary Autotransfusion System Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Cardiopulmonary Autotransfusion System Revenue Forecast by Regions 2019-2025
    • 12.2 Cardiopulmonary Autotransfusion System Market Forecast by Product
      • 12.2.1 Global Cardiopulmonary Autotransfusion System Sales Forecast by Product 2019-2025
      • 12.2.2 Global Cardiopulmonary Autotransfusion System Revenue Forecast by Product 2019-2025
    • 12.3 Cardiopulmonary Autotransfusion System Market Forecast by End User
    • 12.4 North America Cardiopulmonary Autotransfusion System Forecast
    • 12.5 Europe Cardiopulmonary Autotransfusion System Forecast
    • 12.6 Asia Pacific Cardiopulmonary Autotransfusion System Forecast
    • 12.7 Central & South America Cardiopulmonary Autotransfusion System Forecast
    • 12.8 Middle East and Africa Cardiopulmonary Autotransfusion System Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Cardiopulmonary Autotransfusion System Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.

      Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
      The rising prevalence of cardiovascular diseases (CVDs), advancements in technology, and increasing investments in R&D are some of the factors that will propel growth in the cardiopulmonary Autotransfusion systems market in the Americas during the forecast period.
      Cardiac surgeries are complex and may result in a significant loss of blood during deep surgical incisions. This can lower the balance of blood in the body and increase the risks of surgery-induced anemia in people after surgery. This leads to the demand for significant volumes of blood supply, which depends on the complexity of the surgery.
      The global Cardiopulmonary Autotransfusion System market is valued at 510 million US$ in 2018 and will reach 590 million US$ by the end of 2025, growing at a CAGR of 1.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cardiopulmonary Autotransfusion System market based on company, product type, end user and key regions.

      This report studies the global market size of Cardiopulmonary Autotransfusion System in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cardiopulmonary Autotransfusion System in these regions.
      This research report categorizes the global Cardiopulmonary Autotransfusion System market by top players/brands, region, type and end user. This report also studies the global Cardiopulmonary Autotransfusion System market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Haemonetics
      Medtronic
      LivaNova
      Fresenius Kabi
      Terumo
      Wandong Health Sources

      Market size by Product
      Unwashed ATS
      Washed ATS
      Market size by End User
      Heart Surgery
      Great Organ Transplant Surgery
      Other Surgery

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Cardiopulmonary Autotransfusion System market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Cardiopulmonary Autotransfusion System market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Cardiopulmonary Autotransfusion System companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Cardiopulmonary Autotransfusion System submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Cardiopulmonary Autotransfusion System are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cardiopulmonary Autotransfusion System market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now